Exome Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-75,300	Closed	-$128K	–	74
2024 Q3	$128K	Hold	75,300	–	–	0.09%	59
2024 Q2	$103K	Hold	75,300	–	–	0.09%	52
2024 Q1	$282K	Hold	75,300	–	–	0.24%	52
2023 Q4	$739K	Buy	+75,300	New	+$739K	0.73%	42